{
    "nct_id": "NCT03317795",
    "official_title": "Prospective Randomized Trial of Tranexamic Acid Versus Levonorgestrel Intrauterine System for the Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids",
    "inclusion_criteria": "* Premenopausal women ages 25 -50\n* Monthly menses\n* Image-confirmed uterine fibroids of at least 1 cm in size, either submucosal or intramural\n* Seeking treatment for heavy menstrual bleeding following completed clinical evaluation\n* Self-reported heavy menstrual bleeding for three months or longer\n* Completed evaluation for heavy menstrual bleeding within one year of study enrollment\n* Understands the English language for consent and questionnaires\n* Able and willing to provide informed consent\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 25 Years\nMust have maximum age of 50 Years",
    "exclusion_criteria": "* Class 0 fibroids confirmed by hysteroscopy, saline-infused sonogram, or 3D ultrasound\n* Uterine sounding length ≥ 14 cm\n* Uterine size ≥ 20 weeks gestational size\n* Abnormal endometrial biopsy or incomplete clinical testing to rule out malignancy\n* Needs or is using hormonal contraception, including estrogen-containing medications\n* Venous thromboembolic history, clotting disorder, or strong family history of venous thromboembolic events\n* Breast, uterine, or cervical malignancy\n* Liver disease or liver tumor\n* Pelvic inflammatory disease, gonorrhea or chlamydia infection during the past three months\n* Hemoglobin < 8 mg/dL. For women with hemoglobin 8.0 - 12.0 mg/dL, iron supplement is recommended\n* Serum creatinine ≥ 1.4\n* Current pregnancy or currently lactating",
    "miscellaneous_criteria": ""
}